Xvivo Perfusion Ab Stock Market Value
| XVIPF Stock | USD 41.23 0.77 1.83% |
| Symbol | Xvivo |
Xvivo Perfusion 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Xvivo Perfusion's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Xvivo Perfusion.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Xvivo Perfusion on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Xvivo Perfusion AB or generate 0.0% return on investment in Xvivo Perfusion over 30 days. Xvivo Perfusion is related to or competes with Bone Biologics, and Tenon Medical. Xvivo Perfusion AB , a medical technology company, develops solutions for organ, tissue, and cell preservation and perfu... More
Xvivo Perfusion Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Xvivo Perfusion's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Xvivo Perfusion AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 13.19 | |||
| Value At Risk | (3.81) | |||
| Potential Upside | 2.27 |
Xvivo Perfusion Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xvivo Perfusion's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Xvivo Perfusion's standard deviation. In reality, there are many statistical measures that can use Xvivo Perfusion historical prices to predict the future Xvivo Perfusion's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.33) |
Xvivo Perfusion AB Backtested Returns
Xvivo Perfusion AB shows Sharpe Ratio of -0.2, which attests that the company had a -0.2% return per unit of risk over the last 3 months. Xvivo Perfusion AB exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Xvivo Perfusion's Standard Deviation of 1.94, mean deviation of 1.08, and Market Risk Adjusted Performance of (0.32) to validate the risk estimate we provide. The firm maintains a market beta of 0.7, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Xvivo Perfusion's returns are expected to increase less than the market. However, during the bear market, the loss of holding Xvivo Perfusion is expected to be smaller as well. At this point, Xvivo Perfusion AB has a negative expected return of -0.33%. Please make sure to check out Xvivo Perfusion's information ratio, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Xvivo Perfusion AB performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.06 |
Virtually no predictability
Xvivo Perfusion AB has virtually no predictability. Overlapping area represents the amount of predictability between Xvivo Perfusion time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Xvivo Perfusion AB price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Xvivo Perfusion price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.17 |
Xvivo Perfusion AB lagged returns against current returns
Autocorrelation, which is Xvivo Perfusion pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Xvivo Perfusion's pink sheet expected returns. We can calculate the autocorrelation of Xvivo Perfusion returns to help us make a trade decision. For example, suppose you find that Xvivo Perfusion has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Xvivo Perfusion regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Xvivo Perfusion pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Xvivo Perfusion pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Xvivo Perfusion pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Xvivo Perfusion Lagged Returns
When evaluating Xvivo Perfusion's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Xvivo Perfusion pink sheet have on its future price. Xvivo Perfusion autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Xvivo Perfusion autocorrelation shows the relationship between Xvivo Perfusion pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Xvivo Perfusion AB.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Xvivo Pink Sheet
Xvivo Perfusion financial ratios help investors to determine whether Xvivo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xvivo with respect to the benefits of owning Xvivo Perfusion security.